Abstract
Endothelial cells are metabolically active structures lining the inner layer of blood vessels, lymphatic organs and the heart. They have autocrine and paracrine functions and produce various metabolites/substances responsible for vasomotor tone, vessel wall integrity, immunologic processes, pro-coagulation and anti-coagulation homeostasis. Endothelial dysfunction (ED) can be characterized by an abnormality in the physical integrity and/or the functional process of the endothelium which may result in alteration in vasoreactivity, leading to increased propensity for thrombus/plaque formation, leukocyte adhesion with inflammatory changes. ED leads to pathologic conditions such as peripheral vascular disease, cerebral vascular accident, venous thrombosis, cardiovascular disease, chronic kidney disease atherosclerosis, hypertension, diabetes mellitus and neoplasm. This chapter will review Endothelial dysfunction (ED) focusing on the impact it has on perioperative patients and highlighting anesthetic considerations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aird WC. Endothelium in health and disease. Pharmacol Rep. 2008;60(1):139–43.
Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth. 2004;93(1):105–13.
Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000;440:653–66.
Minami T, Aird WC. Endothelial cell gene regulation. Trends Cardiovasc Med. 2005;15(5):174–84.
Aird WC. Phenotypic heterogeneity of endothelium: I. structure, function, and mechanisms. Circ Res. 2007;100(2):158–73.
Florey F. The endothelial cell. Br Med J. 1966;2(5512):487–90.
Pasyk KA, Jakobczak BA. Vascular endothelium: recent advances. Eur J Dermatol. 2004;14(4):209–13.
Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Caccharon JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;5, article 4.
Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;23(supplement 4):S1–S14.
Vanhoutte PM. Regeneration of the endothelium in vascular injury. Cardiovasc Drugs Ther. 2010;24(4):299–303.
Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, et al. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269(6 part 1):C1371–8.
Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003;108(17):2054–9.
Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb Haemost. 2005;3(7):1392–406.
Favero G, Paganelli C, Buffoli B, Rodella LF, Rezzani R. Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int. 2014;2014:801896.
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948–54.
Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101(16):1899–906.
Kolka CM, Bergman RN. The endothelium in diabetes: its role in insulin access and diabetic complications. Rev Endocr Metab Disord. 2013;14(1):13–9.
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70.
Csiszar A, Toth J, Peti-Peterdi J, Ungvari Z. The aging kidney: role of endothelial oxidative stress and inflammation. Acta Physiol Hung. 2007;94(1–2):107–15.
Herrera MD, Mingorance C, Rodriguez-Rodriguez R, de Sotomayor MA. Endothelial dysfunction and aging: an update. Ageing Res Rev. 2010;9(2):142–52.
Price JM, Hellermann A, Hellermann G, Sutton ET. Aging enhances vascular dysfunction induced by the alzheimer’s peptide B-amyloid. Neurol Res. 2004;26(3):305–11.
Burnett AL. The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens. 2006;8(12, supplement 4):53–62.
Sanada M, Taguchi A, Higashi Y, Tsuda M, Kodama I, Yoshizuma M, Ohama K. Forearm endothelial function and bone mineral loss in post-menopausal women. Atherosclerosis. 2004;176(2):387–92.
Mitchell RN, Schoen FJ. Blood vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 525.
Kumar V, Abbas AK, Fausto N, Aster JC. Acute and chronic inflammation. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 47.
Argacha JF, Fontaine D, Adamopoulos D, Ajose A, van de Bome P, Fontaine J, et al. Acute effect of sidestream cigarette smoke extract on vascular endothelial function. J Cardiovasc Pharmacol. 2008;52(3):262–7.
Balakumar P, Sharma R, Singh M. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacol Res. 2008;58(5–6):356–63.
Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201(2):225–35.
Balakumar P, Kaur J. Is nicotine a key player or spectator in the induction and progression of cardiovascular diseases? Pharmacol Res. 2009;60(5):361–8.
Pittilo RM. Cigarette smoking and endothelial injury: a review. Adv Exp Med Biol. 1990;273:61–78.
Bernhard D, Rossmann A, Wick G. Metals in cigarette smoke. IUBMB Life. 2005;57(12):805–9.
Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol. 2007;5(4):276–92.
Luo H-L, Zang W-J, Lu J, Yu X-J, Lin Y-X, Cao Y-X. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat. Basic Clin Pharmacol Toxicol. 2006;99(3):237–45.
Rodella LF, Rossini C, Favero G, Foglio E, Loreto C, Rezzani R. Nicotine-induced morphological changes in rat aorta: the protective role of melatonin. Cells Tissues Organs. 2012;195(3):252–9.
Rodella LF, Favero G, Rossini C, Foglio E, Reiter RJ, Rezzani R. Endothelin-1 as a potential marker of melatonin’s therapeutic effects in smoking-induced vasculopathy. Life Sci. 2010;87(17–18):558–64.
Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis. 2009;205(1):23–32.
Ferrari AU, Radaelli A, Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol. 2003;95(6):2591–7.
Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging. 2003;20(7):527–50.
Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66(2):286–94.
Puca AA, Carrizzo A, Villa F, Ferrario A, Casaburo M, Maciag A, et al. Vascular ageing: the role of oxidative stress. Int J Biochem Cell Biol. 2003;45(3):556–9.
Dia D-F, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110(8):1109–24.
Mitchell RN, Schoen FJ. Blood Vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 498–505.
Glagov S, Weisenberg E, Zavins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. New Eng J Med. 1987;316(22):1371–5.
Kumar V, Abbas AK, Fausto N, Aster JC. Environmental and nutritional diseases. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 415.
Miller DT, Ridker PM, Libby P, Kwiatkowski DJ. Atherosclerosis: the path from genomics to therapeutics. J Am Coll Cardiol. 2007;49:1589.
Rodella LF, Filippini F, Bonomini F, Bresciani R, Reiter RJ, Rezzani R. Beneficial effects of melatonin on nicotine induced vasculopathy. J Pineal Res. 2010;48(2):126–32.
Wang XL, Raveendran M, Wang J. Genetic influence on cigarette induced cardiovascular disease. Prog Cardiovasc Dis. 2003;45(5):361–82.
Ridker P. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129.
Guthikonda S, Haynes W. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep. 2006;8:100.
Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med. 2006;6:501.
Libby P. The vascular biology of atherosclerosis. In: Mann D, Zipes D, Libby P, Bonow R, editors. Braunwald’s heart disease. 7th ed. Philadelphia: Elsevier Saunders; 2005. p. 921.
Hansson G, Robertson AK, Soderber-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1:297.
Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–26.
Mitchell RN, Schoen FJ. Blood Vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 492, 506.
Pinard A, Jones GT, Milewicz DM. Genetics of thoracic and abdominal aortic disease. Circ Res. 2019;124:588–606.
Hobeika M, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg. 2007;45(4):849.
Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006;26(5):987–94.
Jennette J, Falk R. Nosology of primary vasculitis. Curr Opin Rheumatol. 2007;19:10.
Jennette J, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187.
Kumar V, Abbas AK, Fausto N, Aster JC. Diseases of immune system. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 198.
Mitchell RN, Schoen FJ. Blood Vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 511.
Kumar V, Abbas AK, Fausto N, Aster JC. Acute and chronic inflammation. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 53.
Falcini F. Kawasaki disease. Curr Opin Rheumatol. 2006;18:33.
Gedalia A. Kawasaki disease: 40 years after the original report. Curr Rheumatol Rep. 2007;9:336.
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70.
De Jongh RT, Serné EH, Ijzerman RG, de Vries G, Stehouwer CDA. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation. 2004;109(21):2529–35.
Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48(9):1856–62.
Eringa EC, Stehouwer CDA, Roos MH, Westerhof N, Sipkema P. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats. Am J Physiol. 2007;293(5):E1134–9.
Okon EB, Chung AWY, Rauniyar P, Padilla E, Tejerina T, McManus BM, et al. Compromised arterial function in human type 2 diabetic patients. Diabetes. 2005;54(8):2415–23.
Meijer RI, de Boer MP, Groen MR, et al. Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation. 2012;19(6):494–500.
Kostromina E, Gustavsson N, Wang X, Lim CY, Radda GK, Li C, et al. Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas. Endocrinology. 2010;151(5):2050–9.
Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972–8.
Kolka CM, Bergman RN. The endothelium in diabetes: its role in insulin access and diabetic complications. Rev Endocr Metab Disord. 2013;14(1):13–9.
Prakash R, Somanath PR, El-Remessy AB, Kelly-Cobbs A, Stern JE, Dore-Duffy P, et al. Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes. 2012;61(6):1533–42.
Chang SC, Yang WCV. Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med. 2013;2013. 11 pages. 457971.
Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124(4):444–5.
Sharma A, Bernatchez PN, de Haan JB. Targeting endothelial dysfunction in vascular complications associated with diabetes. J Vasc Med. 2012;2012. 12 pages.750126.
Van den Oever AM, Raterman HG et al. Endothelial dysfunction, Inflammation, and apoptosis in diabetes mellitus. Med Inflam. 2017;7.
Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009;119(12):1661–70.
Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009;104(4):541–9.
Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol. 2005;25(12):2594–9.
Withers SB, Agabiti-Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, et al. Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol. 2011;31(4):908–13.
Mitchell RN, Schoen FJ. Blood vessels. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran pathologic basis of diseases. 8th ed. Philadelphia: Elsevier Saunders; 2016. p. 520.
Johansson P, Stensballe, J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care. 2017;21(1):25.
Kim J, Kim K, Lee JH, Jo YH, Kim T, Rhee JE, Kang KW. Prognostic implication of initial coagulopathy in out-of-hospital cardiac arrest. Resuscitation. 2013;84(1):48–53.
Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476–86.
Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112:1289–95.
Stensballe J, Ulrich AG, Nilsson JC, Henriksen HH, Olsen PS, Ostrowski SR, et al. Resuscitation of endotheliopathy and bleeding in thoracic aortic dissection: the viper-Octa randomized clinical pilot trial. Anesth Analg. 2018;127(4):920–7.
Pati S, Potter DR, Baimukanova G, Farrel DH, Holcomb JB, Schreiber MA. Modulating the endotheliopathy of trauma: factor concentrate versus fresh frozen plasma. J Trauma Acute Care Surg. 2016;80:576–84.
Brown MD, Feairheller DL. Are there race-dependent endothelial cell responses to exercise? Exerc Sport Sci Rev. 2013;41(1):44–54. [PMC free article] [PubMed] [Google Scholar]
Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis JA, et al. Effects of exercise training on health status in patients with chronic heart failure HF-ACTION randomized controlled trial. J Am Med Assoc. 2009;301(14):1451–9. [PMC free article] [PubMed] [Google Scholar]
Downing J, Balady GJ. The role of exercise training in heart failure. J Am Coll Cardiol. 2011;58(6):561–9. [PubMed] [Google Scholar]
Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev. 2008;13(1):39–49. [PubMed] [Google Scholar]
Cuevas AM, Germain AM. Diet and endothelial function. Biol Res. 2004;37(2):225–30.
Vogel RA. The Mediterranean diet and endothelial function: why some dietary fats may be healthy. Cleve Clin J Med. 2000;67(4, article 232):235–6. Erratum in Cleveland Clinic Journal of Medicine, vol. 67, no. 7, article 467, 2000
Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;135(3):562–6.
Silva JM, Saldanha C. Diet, atherosclerosis and atherothrombotic events. Rev Port Cardiol. 2007;26(3):277–94.
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano G, D’Armiento M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. J Am Med Assoc. 2004;292(12):1440–6.
Estruch R, MartÃnez-González MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors a randomized trial. Ann Intern Med. 2006;145(1):1–11.
Ryan M, Mcinerney D, Owens D, Collins P, Johnson A, Tomkin GH. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vaso-reactivity. Month J Assoc Phys. 2000;93(2):85–91.
Grassi D, Desideri G, Ferri C. Flavonoids: antioxidants against atherosclerosis. Nutrients. 2010;2(8):889–902.
Rezzani R, Rodella LF, Tengattini S, Bonomini F, Pechanova O, Kojsova S, et al. Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy. J Histochem Cytochem. 2006;54(8):923–32.
Landberg R, Naidoo N, van Dam RM. Diet and endothelial function: from individual components to dietary patterns. Curr Opin Lipidol. 2012;23(2):147–55.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Onyewu, S.C., Coombs, A.T., Kromah, F. (2021). Vascular Endothelial Dysfunction and Inflammatory States. In: Scher, C.S., Kaye, A.D., Liu, H., Perelman, S., Leavitt, S. (eds) Essentials of Blood Product Management in Anesthesia Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-59295-0_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-59295-0_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59294-3
Online ISBN: 978-3-030-59295-0
eBook Packages: MedicineMedicine (R0)